Personal Profile

Song Shijun, professor, chief physician, CPC member, has been engaged in clinical work of oncology for more than 40 years, and was the deputy director of medical oncology department of the Third Affiliated Hospital of Xinxiang Medical College.

He specializes in chemotherapy, minimally invasive therapy, biotherapy and targeted therapy for various solid tumors, especially in the treatment of thoracic tumors such as esophageal cancer, lung cancer, breast cancer, lymphoma, etc. and digestive tumors such as gastric cancer, colorectal cancer and other tumors;

He has extensive experience in diagnosis and treatment of liver cancer, ovarian cancer, cervical cancer, bladder cancer, prostate cancer and other tumors as well as clinically difficult malignant tumors;

He has extensive experience in minimally invasive treatment techniques such as interventional therapy, argon helium knife, radiofrequency ablation, microwave ablation, and radioactive iodine particle implantation therapy;

In the long-term oncology clinical work, Director Song actively researches and accumulates rich results, has participated in the research of the National Natural Science Foundation of China 2 projects, 3 projects at the local hall level, presided over the Xinxiang City Science and Technology Tackling Project 1 project,published more than 20 papers, including 3 SCI papers, and participated in the compilation of 6 academic monographs.

Educational background:

Zhejiang University Of Medicine, ClinicalMedicine

Engage In Advanced Studies  In Shanxi Medical UniversityClinicalOncologyMasterClass

Engage In Advanced Studies  In Beijing China-Japan Friendship Hospital

Engage In Advanced Studies  In Chinese Academy Of Medical Sciences Cancer Hospital

Engage In Advanced Studies In Nanfang Hospital Of Southern Medical University

Medical experience:

Member of Chinese Anti-Cancer Association and Chinese Clinical Oncology Society (CSCO) 

Member of the American Society of Oncology (ASCO).

Member of the European Society of Oncology (ESMO)      

Member of Henan Anti-Cancer Association

Member of the Standing Committee of the Oncology and Chemotherapy Professional Committee of Henan Anti-Cancer Association

Member of Standing Committee of Cancer Precision Medicine Therapy Professional Committee of Henan Anti-Cancer Association

Member of the Standing Committee of Henan Provincial Anti-Cancer Association Tumor Molecular Medicine Therapy Professional Committee

Member of Tumor Biotherapy Committee of Henan Anti-Cancer Association

Member of the Lung Cancer Professional Committee of Henan Anti-Cancer Association

Member of Esophageal Cancer Professional Committee of Henan Anti-Cancer Association

Member of Liver and Biliary Tumor Tumor Committee of Henan Anti-Cancer Association

Member of Breast Cancer Professional Committee of Henan Anti-Cancer Association

Member of Clinical Society of Tumor Drugs, Henan Anti-Cancer Association

Committee member of Neuroendocrine Tumor Society of Henan Anti-Cancer Association

Expert member of medical malpractice and medical damage appraisal of Henan Medical Association

Research direction:

oncology

*Surgery, in addition to the appropriate chemotherapy and radiotherapy, are effective in treating early cancer, but certain patients in late stage of cancer may not be tolerate surgery well as they can be relatively weak. A combination of carefully planned minimally invasive therapy, chemotherapy or radiotherapy can effectively reduce the side effects and discomfort of treatment and may help patient get better efficacy.